tirzepatide tips for use How to Inject (Zepbound/Mounjaro): A Step-By-Step Guide Tirzepatide Injection Training

Haskell-Luevano C, et al

Among Americans who have never taken GLP-1s but are considering beginning treatment in the next 12 months, 25.1% cite the pill option as the primary factor influencing their desire to begin treatment, and among the 9.3% of Americans who have discontinued GLP-1 treatments, 44.1% say they are considering resuming treatments because of pill options

As expected, gastrointestinal adverse events were more frequent in the semaglutide group

Among large employers with 5,000 or more employees, 66% reported that covering GLP-1s for weight loss had a significant impact on their prescription drug spending

Remember, your path to health is unique, and were here to support you every step of the way